University of New Mexico Health Sciences Center
|
Last Name Index: Boedeker Brinker Buranda Burgos Byrd Chackerian Chand Deretic Durvasula Ebel Edwards Goade Gresham Harrod Hjelle Hutt Kajon Koster Larson Lee Lidke Lipscomb Lovchik Lyons May Mertz Moseley Oliver Ohls Ozbun Panganiban Peabody Perkins Prossnitz Rubin Sklar Tesfaigzi Timmins Vergne Wheeler Wilder Wilson Williams |
|||
|
CIDI
Members |
Research Interests |
||
|
Edgar C. Boedeker, MD |
Pathogenesis of bacterial infections of the intestinal tract; animal models for the study of intestinal infection & immunity; the role of virulence factors of pathogenic E. coli strains in disease and immunity. |
|
|
C. Jeffrey Brinker, PhD |
New areas of nanomaterials science at the interface of living organisms and nanostructured materials with the goals of enhancing biocompatibility; developing new hierarchical nano/bio structures with new behaviors and functions. |
|
|
Tione Buranda, PhD |
Membrane Organization, lipid rafts and mechanism of viral infection. Cell signaling and adhesion. Spectroscopy (microscopy, flow cytometry, steady state and time resolved spectrofluorometry, FRET). |
|
|
Marcos Burgos, MD |
International health, tuberculosis control programs, drug-resistant tuberculosis and molecular epidemiology. |
|
|
Thomas F. Byrd III, MD |
Mycobacterial pathogenesis, including Mycobacterium tuberculosis and nontuberculous mycobacteria. [top]
|
|
|
Bryce Charles Chackerian, PhD |
Development of new vaccines against self-antigens that are involved in disease processes; use of virus particles as platforms for antigen display. |
|
|
|
Hitendra S. Chand, PhD |
Microbial pathogenesis and host response; lung infection and immunobiology; multispectral imaging and analysis; role of proteinase inhibitors in carcinogenesis and thrombosis |
|
|
Vojo Deretic, PhD |
Cell biology of micobial pathogenesis: HIV; tuberculosis; confocal microscopy; autophagy. |
|
|
Ravi Venkata Durvasula, MD |
Transgenic & paratransgenic approaches to control of vector-borne diseases such as Chagas disease and Leishmaniasis. |
|
|
Gregory D. Ebel, PhD |
Contribution of ecological/evolutionary dynamics of RNA viruses to pathogenesis, persistence & emergence; contributions of replication & intra-host genetic diversity of RNA virus populations toward their ability to infect diverse hosts & their replication fitness. [top]
|
|
|
Jeremy S. Edwards, PhD |
Spatial-temporal modeling of signaling networks and functional genomics tool development. |
|
|
Diane Goade, MD |
Clinical and molecular virology research, with an emphasis on herpes simplex and hantaviruses. |
|
|
Hattie D. Gresham, PhD |
The role of phagocytes, particularly neutrophils, in host defense against infectious diseases. |
|
|
Kevin S. Harrod, PhD |
Development of animal models to explore the role of the lung epithelium in innate immunity and host defense to viral and bacterial infection. |
|
|
Brian L. Hjelle, MD |
Pathogenesis, immunology, epidemiology, molecular biology and diagnosis of human virus infections. [top]
|
|
|
|
Julie A. Hutt, DVM, PhD, DACVP |
Molecular mechanisms of signal transduction and quantitative fluorescence microscopy. |
|
|
Adriana E. Kajon, PhD |
Molecular epidemiology of adenovirus respiratory infections; pathogenesis of adenovirus respiratory infections; animal models of viral pathogenesis; genetic variability & evolution of adenoviruses. |
|
|
Frederick T. Koster, MD |
Cellular immunology; lymphocytes participating in the immunopathogenesis of Hantavirus Cardiopulmonary Syndrome; hantavirus & cardiogenic shock; comparison of vitro virus behavior among pathogenic & non-pathogenic hantaviruses. |
|
|
Richard S. Larson, MD, PhD |
Mechanisms of cell adhesion, micro-Array analysis of T-lineage acute lymphoblastic leukemia and small molecule and Drug discovery. |
|
|
Samuel A. Lee, MD, PhD |
Molecular pathogenesis of invasive candidiasis & translational aspects of Candida infection, including mechanisms of echinocandin resistance & molecular epidemiology of oral candidiasis in immunosuppressed patients. [top]
|
|
|
|
Diane S. Lidke, PhD |
Molecular mechanisms of signal transduction and quantitative fluorescence microscopy. |
|
|
Mary Fisher Lipscomb, MD |
Pulmonary immune regulation in infection and asthma. |
|
|
|
Julie A. Lovchik, PhD |
||
|
C. Rick Lyons, MD, PhD |
Mechanisms by which innate & acquired immunity protect against pulmonary challenge with category A pathogens Bacillus anthracis, Francisella tularensis & smallpox; murine pulmonary animal models for anthrax, virulent tularemia & cowpox virus. |
|
|
Elebeoba "Chi-Chi" May, PhD |
Genetics of host-pathogen interactions; latency & reactivation in a murine model of Mycobacterium tuberculosis infection; modeling & analysis of molecular systems; protein translation initiation mechanism of bacterial systems. [top]
|
|
|
Gregory J. Mertz, MD |
Ecology, pathogenesis, epidemiology & treatment of hantavirus cardiopulmonary syndrome in Chile; ecology & epidemiology of hantavirus infection in Panama; genital herpes infections, including epidemiology, transmission, diagnosis, management & prevention. |
|
|
Pope Moseley, MD MS |
Heat stress and the regulation of the heat shock response. |
|
|
Robin K. Ohls, MD |
Efficacy of erythropoietin therapy in decreasing the need for red blood cell transfusions in term and preterm infants with congenital heart disease; pathophysiology of the anemia of prematurity using human fetal liver and kidney cultures. |
|
|
Janet M. Oliver, PhD |
Signal Transduction in hematopoietic and cancer cells. |
|
|
Michelle A. Ozbun, PhD |
Differentiation-dependent life cycles of papillomavirus; strategies of initial PV replication upon infection & the mechanisms for establishment of viral persistence; step(s) of PV infection at which host range & tissue tropism are demonstrated. [top]
|
|
|
Antonito Panganiban, PhD |
Mechanism by which virus particles are able to efficiently exit virus-producing cells; role of higher order RNA structure in successful replication of viral nucleic acid. |
|
|
David Peabody, PhD |
Protein-RNA Interactions. |
|
|
|
Douglas J. Perkins, PhD |
Genetic basis of severe malarial anemia. |
|
|
Eric R. Prossnitz, PhD |
Mechanisms of activation & inactivation of G protein-coupled receptors & of receptor processing following activation & the role of arrestins in these processes; the G protein-coupled estrogen receptor GPR30. |
|
|
Robert L. Rubin, PhD |
Cellular and molecular basis for the capacity of lupus-inducing drugs to disrupt central T cell tolerance. [top]
|
|
 |
Larry A. Sklar, PhD |
Signal transduction, cell adhesion, Leukocyte Biology, High Throughput technologies for molecular assembly and drug discovery. |
|
|
Yohannes Tesfaigzi, PhD |
Role of cytokines & other inflammatory mediators in regulating signaling of apoptosis in airway epithelial cells; regulation of homeostasis in airway epithelia; gene polymorphisms & susceptibility to smoking-induced emphysema/chronic bronchitis. |
|
|
Graham Timmins, PhD |
Mechanisms of action and roles of free radicals in the control of infectious disease. |
|
|
Isabelle Vergne, PhD |
||
|
Cosette Wheeler |
Natural history of human papillomavirus (HPV) infections & the development of cervical cancer & its precursor lesions; cervical cancer prevention efforts through the use of recombinant HPV virus-like particle (VLP) vaccines. [top]
|
|
|
Julie A. Wilder, PhD |
Development & consequences of immune responses that manifest themselves in the lung; contribution of environmental tobacco smoke exposure to the development & chronicity of the allergic asthmatic response in the lung. |
|
|
Bridget S. Wilson, PhD |
Signal transduction through IgE Receptors (FcεRI) & ErbB family of growth factor receptors; plasma membrane microdomains for signaling & internalization; spatio-temporal aspects of cell signaling. |
|
|
Thomas M Williams, MD |
Immunogenetics in humans and non-human primates; molecular pathology. [top]
|
|
